Orlistat is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name Xenical by Roche in most countries, and is sold over-the-counter as Alli by GlaxoSmithKline in the United Kingdom and the South African State.
How Much Does Xenical Cost In South Africa
The cost for Xenical oral capsule 120 mg is around R10975.77 for a supply of 90 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Is Xenical good for weight loss?
Xenical (orlistat) blocks some of the fat that you eat, keeping it from being absorbed by your body. Xenical is used to aid in weight loss, or to help reduce the risk of regaining weight already lost. This medicine must be used together with a reduced-calorie diet and is to used only by adults.
How much weight can you lose on Xenical in a month?
A clinical trial has found that participants who took Xenical three times a day lost an average of 4.8kg in the first month, increasing up to 7.2kg at 3 months. After a year, the average loss was 10% of original body weight.
What foods go with Xenical?
What to eat when taking Xenical/Orlistat
Cereal or porridge and semi-skimmed milk with: Fruit or one glass of unsweetened fruit juice.
Bread or toast with: Low-fat spread and jam or marmalade. Fruit or one glass of unsweetened fruit juice.
How long does Xenical take to work?
Xenical should be taken every day to be effective. Weight loss normally starts within 2 weeks and continues for 6 to 12 months on Xenical treatment. Xenical will then help you to maintain this new lower weight and help to prevent weight being regained.
What are the side effects of Xenical?
COMMON side effects
low vitamin D levels.
discharge of stools when passing gas.
the inability to control a bowel movement.
a strong desire to have bowel movement.
oily rectal discharge.
loose stools.
increased number of bowel movements.
intense abdominal pain.
Can you take Xenical long term?
Orlistat and sibutramine are widely prescribed ant obesity agents that are approved for 2 years of continuous use. Previous 1–4-year randomized, placebo-controlled trials of these drugs have reported average weight losses of <5 kg, significant adverse effects and attrition rates of up to 60%.